These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22119332)

  • 1. Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements.
    Gálvez J; Lecina M; Solà C; Cairó JJ; Gòdia F
    J Biotechnol; 2012 Jan; 157(1):214-22. PubMed ID: 22119332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.
    Henry O; Dormond E; Perrier M; Kamen A
    Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperosmotic pressure on HEK 293 cells during the growth phase, but not the production phase, improves adenovirus production.
    Shen CF; Kamen A
    J Biotechnol; 2012 Jan; 157(1):228-36. PubMed ID: 22154564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
    Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
    J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
    Côté J; Garnier A; Massie B; Kamen A
    Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
    Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors.
    Yuk IH; Olsen MM; Geyer S; Forestell SP
    Biotechnol Bioeng; 2004 Jun; 86(6):637-42. PubMed ID: 15137074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
    Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
    Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system.
    Liu YK; Yang CJ; Liu CL; Shen CR; Shiau LD
    J Biosci Bioeng; 2010 Aug; 110(2):187-93. PubMed ID: 20547323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the first to the third generation adenoviral vector: what parameters are governing the production yield?
    Dormond E; Perrier M; Kamen A
    Biotechnol Adv; 2009; 27(2):133-44. PubMed ID: 19013226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring.
    Côté J; Bourget L; Garnier A; Kamen A
    Biotechnol Prog; 1997; 13(6):709-14. PubMed ID: 9413130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessing culture media and critical metabolites that affect adenovirus production.
    Shen CF; Voyer R; Tom R; Kamen A
    Biotechnol Prog; 2010; 26(1):200-7. PubMed ID: 19728394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
    Xie L; Pilbrough W; Metallo C; Zhong T; Pikus L; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2002 Dec; 80(5):569-79. PubMed ID: 12355468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.